Pharmacotherapy of amphetamine-type stimulant dependence: an update
about
The Effects of Naltrexone on Subjective Response to Methamphetamine in a Clinical Sample: a Double-Blind, Placebo-Controlled Laboratory Study.Chronic methamphetamine abuse and corticostriatal deficits revealed by neuroimaging.Methamphetamine: an update on epidemiology, pharmacology, clinical phenomenology, and treatment literatureIntimate partner violence and reproductive health among methamphetamine-using women in los angeles: a qualitative pilot study.Randomized, placebo-controlled trial of bupropion in methamphetamine-dependent participants with less than daily methamphetamine useMethamphetamine self-administration in humans during D-amphetamine maintenance.Treatment of rats with an anti-(+)-methamphetamine monoclonal antibody shortens the duration of action of repeated (+)-methamphetamine challenges over a one month periodClinical potential of methylphenidate in the treatment of cocaine addiction: a review of the current evidence.Biomedical HIV Prevention Including Pre-exposure Prophylaxis and Opiate Agonist Therapy for Women Who Inject Drugs: State of Research and Future Directions.Clinical features, course and treatment of methamphetamine-induced psychosis in psychiatric inpatientsEffects of 7-day continuous D-amphetamine, methylphenidate, and cocaine treatment on choice between methamphetamine and food in male rhesus monkeys.Combining Active Immunization with Monoclonal Antibody Therapy To Facilitate Early Initiation of a Long-Acting Anti-Methamphetamine Antibody ResponseStudy protocol: a dose-escalating, phase-2 study of oral lisdexamfetamine in adults with methamphetamine dependenceMethamphetamine treatment outcomes among gay men attending a LGBTI-specific treatment service in Sydney, AustraliaMethamphetamine-like discriminative stimulus effects of bupropion and its two hydroxy metabolites in male rhesus monkeysAbuse Potential of Oral Phendimetrazine in Cocaine-dependent Individuals: Implications for Agonist-like Replacement Therapy.Single nucleotide polymorphism near CREB1, rs7591784, is associated with pretreatment methamphetamine use frequency and outcome of outpatient treatment for methamphetamine use disorder.Ibudilast attenuates subjective effects of methamphetamine in a placebo-controlled inpatient studyNaltrexone moderates the relationship between cue-induced craving and subjective response to methamphetamine in individuals with methamphetamine use disorder.Dropout in clinical trials of pharmacological treatment for methamphetamine dependence: the role of initial abstinence.Utility of preclinical drug versus food choice procedures to evaluate candidate medications for methamphetamine use disorder.Initiation of drug dealing among a prospective cohort of street-involved youthSafety of Intravenous Methamphetamine Administration During Ibudilast Treatment.Effects of 7-day repeated treatment with the 5-HT2A inverse agonist/antagonist pimavanserin on methamphetamine vs. food choice in male rhesus monkeys.Acute buspirone dosing enhances abuse-related subjective effects of oral methamphetamine.Polydrug use and its association with drug treatment outcomes among primary heroin, methamphetamine, and cocaine users.Buspirone maintenance does not alter the reinforcing, subjective, and cardiovascular effects of intranasal methamphetamine.A Novel PKC Inhibitor Shows Promise for Amphetamine Use Disorders.Atomoxetine for amphetamine-type stimulant dependence during buprenorphine treatment: A randomized controlled trial.Extended-Release Injectable Naltrexone (XR-NTX) With Intensive Psychosocial Therapy for Amphetamine-Dependent Persons Seeking Treatment: A Placebo-Controlled Trial.
P2860
Q27310644-34D025B1-0E99-4932-95ED-DD893382200AQ30873118-81895B52-F481-40E1-9BE9-735CBB4AB0FBQ34181746-52C1D1A4-0446-4EA5-8CC9-C39FAD12CC5CQ34301853-975EAA2C-9FF2-4D33-BFC3-3FC341DE5AADQ34315501-2E23CD55-90F1-4850-8210-D60D7623BDE8Q34550457-33EAF84C-E35B-4AC1-91B2-2368D2B78001Q34602548-6BD60868-2E71-4CE5-BFDD-6BD0FA9195A9Q35766564-73D298E9-0DA9-4341-ADBC-306C44B97609Q35817533-FBE72754-661F-44CE-B6EE-C2A398FF2895Q35934610-80258E95-A214-4C3D-B5E7-64BB09EE66C8Q36090475-C6EC0DFC-4031-404D-9302-A94DD02720D3Q36148294-6B820609-6CA9-4CD3-AED5-726D99EF851AQ36209156-3B466BBB-2758-4217-B921-40D4168FF880Q36283064-CAC911A6-DC60-40B4-B6A7-A8BAD333CC73Q36655731-584D70DA-D473-4EC7-8F64-8B309DCCB0D4Q36936280-B24CB70D-D575-4C8D-A976-4BD37F517444Q37316136-031ECAA7-A7A8-4FE1-B52F-D00608B8E4D1Q37698675-290D21BE-ED6C-49BA-B791-043EF04E85EDQ38867904-C56CEF7F-EB3B-41E5-9862-25060D59C3BCQ39009620-53A203D4-FDBE-4708-96A6-B8F09DCE006AQ39034288-28BF188F-3B18-47DA-93C4-04E921BB2582Q39675132-21F90991-18B3-4937-A610-5C7A4FD6EF49Q39704909-51527935-7580-4773-B0B6-D5D4E723B760Q39724020-24D13FFC-0FD2-43CB-BC04-37E9539C3E83Q42841373-04B7A015-B88E-4627-8736-CB5250D045FAQ46433374-11ABEEC5-520F-4435-82FF-057069F97591Q47610819-2AADB64A-2723-43BF-94E3-3B59AA22D7C0Q48308055-BFBCDE21-397F-4BEE-A6A3-E5F7E6919B52Q51735563-013C9A96-9F44-4CA4-93DC-84F34A909106Q55663366-C8E86A1B-0354-4EE3-951C-C473D3B78013
P2860
Pharmacotherapy of amphetamine-type stimulant dependence: an update
description
2013 nî lūn-bûn
@nan
2013 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Pharmacotherapy of amphetamine-type stimulant dependence: an update
@ast
Pharmacotherapy of amphetamine-type stimulant dependence: an update
@en
Pharmacotherapy of amphetamine-type stimulant dependence: an update
@nl
type
label
Pharmacotherapy of amphetamine-type stimulant dependence: an update
@ast
Pharmacotherapy of amphetamine-type stimulant dependence: an update
@en
Pharmacotherapy of amphetamine-type stimulant dependence: an update
@nl
prefLabel
Pharmacotherapy of amphetamine-type stimulant dependence: an update
@ast
Pharmacotherapy of amphetamine-type stimulant dependence: an update
@en
Pharmacotherapy of amphetamine-type stimulant dependence: an update
@nl
P2093
P2860
P356
P1476
Pharmacotherapy of amphetamine-type stimulant dependence: an update
@en
P2093
Keith G. Heinzerling
Matthew Brensilver
Steven Shoptaw
P2860
P304
P356
10.1111/DAR.12048
P407
P577
2013-09-01T00:00:00Z